FRA:V59 (China)
Â
Ordinary Shares-Class H
€
1.306
+0.038 (+3%)
Aug 7
Business Description
Xuanzhu Biopharmaceutical Co Ltd
ISIN : CNE1000074Q1
Share Class Description:
FRA:V59: Ordinary Shares-Class HTotal Employee Number:
342Compare
Compare
Traded in other countries / regions
02575.Hong KongV59.Germany IPO Date
2026-03-27Description
Xuanzhu Biopharmaceutical Co Ltd is an innovation-driven biopharmaceutical company in China, leveraging its understanding of China's pharmaceutical industry and insights of its clinical needs to improve patient health and life. It has over ten drug assets under active development covering digestive diseases, oncology, and NASH. Its track record also includes the successful development of four drug candidates that were subsequently transferred and/or out-licensed to pharmaceutical companies. Its pipeline is staggered and complementary in structure, covering both validated targets with druggability as well as new mechanisms of action and drug modalities, established therapeutic areas such as oncology, and high-growth potential therapeutic areas such as NASH.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1007.75 | |||||
Equity-to-Asset | 0.84 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 11 | |||||
Beneish M-Score | -1.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.75 | |||||
9-Day RSI | 54.55 | |||||
14-Day RSI | 46.71 | |||||
3-1 Month Momentum % | -28.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.75 | |||||
Quick Ratio | 3.36 | |||||
Cash Ratio | 2.94 | |||||
Days Inventory | 1293.69 | |||||
Days Sales Outstanding | 47.63 | |||||
Days Payable | 1889.55 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.48 | |||||
Operating Margin % | -418.72 | |||||
Net Margin % | -473.68 | |||||
EBITDA Margin % | -415.43 | |||||
FCF Margin % | -487.4 | |||||
OCF Margin % | -405.17 | |||||
ROE % | -23.41 | |||||
ROA % | -19.03 | |||||
ROIC % | -26.1 | |||||
ROC (Joel Greenblatt) % | -165.27 | |||||
ROCE % | -22.25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 113.45 | |||||
PB Ratio | 4.27 | |||||
Price-to-Tangible-Book | 8.16 | |||||
EV-to-EBIT | -21.15 | |||||
EV-to-EBITDA | -24.11 | |||||
EV-to-Revenue | 100.15 | |||||
EV-to-FCF | -20.57 | |||||
| Price-to-Net-Current-Asset-Value | 10.05 | |||||
| Price-to-Net-Cash | 14.51 | |||||
Earnings Yield (Greenblatt) % | -4.73 | |||||
FCF Yield % | -4.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Xuanzhu Biopharmaceutical Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 6.268 | ||
| EPS (TTM) (€) | -0.064 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 46.71 | ||
| 14-Day ATR (€) | 0.059428 | ||
| 20-Day SMA (€) | 1.2712 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 1.128 - 3.9 | ||
| Shares Outstanding (Mil) | 517.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Xuanzhu Biopharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Xuanzhu Biopharmaceutical Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Xuanzhu Biopharmaceutical Co Ltd Frequently Asked Questions
What is Xuanzhu Biopharmaceutical Co Ltd(FRA:V59)'s stock price today?
The current price of FRA:V59 is €1.31. The 52 week high of FRA:V59 is €3.90 and 52 week low is €1.13.
When is next earnings date of Xuanzhu Biopharmaceutical Co Ltd(FRA:V59)?
The next earnings date of Xuanzhu Biopharmaceutical Co Ltd(FRA:V59) is .
Does Xuanzhu Biopharmaceutical Co Ltd(FRA:V59) pay dividends? If so, how much?
Xuanzhu Biopharmaceutical Co Ltd(FRA:V59) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Xuanzhu Biopharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers